A multi-centre double-blind placebo-controlled randomised trial of a combination of methotrexate and gefitinib versus methotrexate alone as a treatment for ectopic pregnancy – GEM3

  • Horne, Andrew W (Primary Chief Investigator (PCI))
  • Mol, Ben (Chief Investigator (CI))
  • Tong, Steven Y.C. (Chief Investigator (CI))

Project: Research

Project Details

Project Description

This study is a multi-centre clinical trial investigating treatment options for tubal ectopic pregnancy. In this trial the efficacy of gefitinib and methotrexate combined versus methotrexate alone is assessed. The project was awarded a grant from the National Institute for Health Research in the UK.
Funding awarded to MRC Centre for Reproductive Health, University of Edinburgh, Queen's Medical Research Institute.
Amount awarded: GB Pounds 1,144,836.91
AcronymGEM3
StatusActive
Effective start/end date1/04/1631/10/20

Keywords

  • clinical trial
  • ectopic pregnancy
  • gefinitib
  • methotrexate